Ethris Competitors and Similar CompaniesClear all
Ethris's competitors and similar companies include Asklepios BioPharmaceutical and ProQR Therapeutics.
 Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia. |  Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. |  ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. | |
Founding Date | Founding Date 2009 | Founding Date 2001 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Planegg, DE HQ | Locations Chapel Hill, US HQ Roslin, GB | Locations Leiden, NL HQ Cambridge, US |
Employees | Employees 504% decrease | Employees 5172% increase | Employees 166 |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 235m | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
Asklepios BioPharmaceutical
HQ
Chapel Hill, US
Employees
517↑ 2% increase
Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.
View companyProQR Therapeutics
HQ
Leiden, NL
Employees
166
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
View company